Fast-track scheme for ‘breakthrough’ technology could speed up NHS adoption by four years

Written by Sam Trendall on 4 November 2017 in News

Government puts £86m funding into programme to accelerate health-service adoption of innovative medicines and tech

The government is to launch a new fast-track scheme that could see the best new medical technologies deployed in the NHS four years quicker than they are currently.

In April, the government will launch an “accelerated access pathway”, which aims to allow the most innovative new technologies and medicines to be sped through the NHS’s evaluation and financial-approval process. This could mean new ways of treating conditions such as cancer, dementia, and diabetes are offered to patients as much as four years sooner than they would otherwise have been, the government said.

Products designated as “breakthrough” treatments will receive support with development, and also with going through the various approval processes that need to be successfully negotiated before NHS bodies are allowed to buy and deploy new products.

Related content

The government is also providing £86m of funding “to help innovators of all sizes gain access to the NHS market”, and ensure the best new technologies get to patients faster. Included in this is a four-year, £35m package aimed at helping SMEs in the digital space “build a stronger evidence base for their products”. A further £6m will be invested in helping companies from the “medtech, diagnostics, and pharmaceutical” sectors do the same.

Another £6m is to be committed to assisting clinicians in rolling out new technologies and medicines in their day-to-day operations. Some £39m, meanwhile, will go towards helping 15 regional Academic Health Science Networks “encourage grassroots adoption and uptake of new medical technologies”.

Health minister Lord O’Shaughnessy said: “I want the UK to be the best place in the world to develop new drugs and medical technology. But, despite the innovation happening here, our uptake in the NHS can be too slow. Today’s new measures will not only benefit patients by improving how quickly and easily we can get innovative products from the lab to the bedside, but will guarantee future collaboration between the life-sciences sector and the NHS, post-Brexit – benefitting the British economy, and creating jobs.”


About the author

Sam Trendall is editor of PublicTechnology


Share this page




Please login to post a comment or register for a free account.

Related Articles

EXCL: Digital chief on why HMRC must 'embrace AI and machine learning'
20 May 2019

CDIO Jacky Wright tells PublicTechnology that department wants to focus on developing its use of artificial intelligence tools

Which government department suffers the most data breaches?
10 May 2019

Since 2008 departments have been required to report data breaches every year. In this exclusive research – kicking off two weeks of dedicated cybersecurity content on PublicTechnology – SA...

Government to ‘consider options’ for biometrics regulation
9 May 2019

Immigration minister indicates that various courses of action will be examined before any legislation is passed